Currently, the traditional treatment of DN is mainly based on weight reduction, blood pressure and glucose control, and the use of renin-angiotensin system inhibitors (RASIs), including angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) as the first-line medication for DN (6). This evidence concerns the gene REN and liver dysplastic nodule.